This collection is part of a series of SynBioBeta 2026 Research Topics. Please see other Research Topics in the collection here:SynBioBeta 2026: ...
Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results